Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised double-blind trial of combination antibiotic therapy in rheumatoid arthritis
2004-004893-96Phase 3Completed
- Sponsor
- Hammersmith Hospitals NHS Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Clindamycin + tetracycline with Placebo (2 arms). Primary endpoint: ACR20 response at 6 months. Started Feb 2005; status: completed.
02
Drugs
clindamycintetracycline
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-004893-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004893-96.